Prudential Financial
KRSA

Prudential Financial’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Prudential Financial’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-373
Closed -$29K – 2665
2022
Q2 		$29K Buy
+373
New +$5.34K ﹤0.01% 2622
2019
Q4 		– Sell
-144
Closed -$244K – 2440
2019
Q3 		$244K Sell
144
-125
-46% -$27K ﹤0.01% 2262
2019
Q2 		$432K Buy
+269
New +$76.1K ﹤0.01% 2134

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Prudential Financial's KRSA Position: Q3 2022 in Review

Prudential Financial sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2022, closing a stake of 373 shares — an estimated $29K sold.

Prudential Financial first reported a position in KRSA in Q2 2019 and held it in 3 quarters. The position peaked at $432K in Q2 2019. 34 funds tracked by Wall St. Rank hold KRSA as of Q3 2022.

  • Prudential Financial reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Prudential Financial sold 373 Korsana Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $29K.
  • Prudential Financial first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • Prudential Financial's Korsana Biosciences, Inc. Common Stock position peaked at $432K in Q2 2019.
  • 34 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2022.

Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.